Type 1 diabetes nearly triples dementia risk - a finding that surprised even researchers

Type 2 diabetes has long been recognized as a risk factor for dementia. The connection is well-documented, biologically plausible, and widely discussed in clinical practice. But type 1 diabetes - the autoimmune form that accounts for just 5% of diabetes cases - has received far less attention on this front, in part because people with type 1 historically did not live long enough for dementia to become a major concern.

That has changed. Advances in insulin therapy, continuous glucose monitoring, and clinical management have extended life expectancy for people with type 1 diabetes significantly. Many now live well into their seventies and eighties. And with those extra decades comes a question the field has been slow to confront: what happens to the brain after a lifetime of managing a disease defined by metabolic instability?

Nearly three times the risk

A study published March 18, 2026 in Neurology, the medical journal of the American Academy of Neurology, provides an answer that is both clear and unsettling. Among 283,772 participants with an average age of 64, those with type 1 diabetes were nearly three times as likely to develop dementia as those without any form of diabetes. People with type 2 diabetes were twice as likely. The rarer condition carried the stronger association - a result the researchers themselves found striking.

The numbers break down sharply. Of the 5,442 participants with type 1 diabetes, 144 developed dementia during the study's average follow-up period of 2.4 years - a rate of 2.6%. Among the 51,511 participants with type 2 diabetes, 942 developed dementia, or 1.8%. And of the 226,819 people without diabetes, 1,262 developed dementia, just 0.6%.

After adjusting for age, education level, and other confounding factors, the researchers estimated that an extraordinary 65% of dementia cases among people with type 1 diabetes could be attributed to the condition itself. That figure deserves a pause. It suggests that for people with type 1 diabetes who develop dementia, the diabetes is not merely a background factor - it is, statistically speaking, the primary driver in nearly two-thirds of cases.

Why type 1 may hit the brain harder

"We have known that type 2 diabetes is linked to an increased risk of dementia, but this new research suggests that, unfortunately, the association may be even stronger for those with type 1 diabetes," said study author Jennifer Weuve, MPH, ScD, of Boston University.

The study does not explain the mechanism. It shows an association, not a cause. But there are plausible biological reasons why type 1 diabetes might exact a heavier cognitive toll than type 2. People with type 1 typically live with the disease for decades longer than those diagnosed with type 2, which usually emerges in midlife or later. A person diagnosed with type 1 at age eight has been managing the disease for over 50 years by the time they reach their sixties. That means decades more exposure to blood sugar fluctuations, episodes of severe hypoglycemia, and the vascular damage that chronically elevated glucose inflicts on small blood vessels - including the delicate capillaries that supply the brain.

Severe hypoglycemia - episodes where blood sugar drops dangerously low - is more common in type 1 diabetes and can cause acute neurological damage. Over a lifetime, repeated hypoglycemic episodes may have cumulative effects on brain structure and function. At the other extreme, chronic hyperglycemia promotes inflammation, oxidative stress, and the formation of advanced glycation end products - molecular debris that accumulates in tissues and contributes to vascular disease. The brain, which depends on a constant supply of glucose delivered through intact blood vessels, is particularly vulnerable to both extremes.

Type 1 diabetes also involves autoimmune processes that type 2 does not. The immune system attacks and destroys the insulin-producing beta cells of the pancreas. Whether that autoimmune activity extends to or influences the central nervous system - contributing independently to neurodegeneration - is an open question, but one that these findings make more urgent to investigate.

A growing population at risk

Weuve was careful to contextualize the findings in population terms. Type 1 diabetes is uncommon, so it accounts for a small fraction of all dementia cases in the general population. The public health burden of type 2 diabetes-related dementia, driven by sheer numbers, remains far larger. There are roughly 37 million people with diabetes in the United States, and type 2 accounts for about 95% of cases.

But the individual risk matters. The number of people with type 1 diabetes surviving past age 65 is growing steadily - a direct consequence of better care. For that population, these findings represent a concrete and personal concern that warrants clinical attention and sustained research investment.

"For the growing number of people with type 1 diabetes who are over 65 years old, these findings underscore the urgency of understanding the ways in which type 1 diabetes influences dementia risk and how we can prevent or delay it," Weuve said.

Study design and its constraints

The study drew on data from a cohort of 283,772 people followed for an average of 2.4 years. Diabetes and dementia diagnoses were identified through electronic health records and survey data - a standard approach for studies of this scale, but one with recognized limitations. Electronic health records may miss diagnoses, particularly early-stage dementia that has not yet prompted a formal clinical evaluation or that presents as "normal aging" rather than a distinct disorder. Records may also misclassify diabetes type, a common problem since the distinction between type 1 and type 2 is not always clearly documented, especially in older adults.

The follow-up period of 2.4 years is relatively short for a study of dementia, which typically develops over decades. Many participants who showed no signs of dementia during the study period may develop it later. A longer observation window might reveal different patterns, potentially strengthening the associations already observed, or it might show that some of the excess risk attenuates over time as competing causes of death remove people from the cohort.

Most critically, this is an observational study. It demonstrates that type 1 diabetes and dementia occur together more often than chance would predict, but it cannot prove that one causes the other. Unmeasured confounders - factors that the study did not account for, such as cardiovascular disease burden, physical activity levels, or depression - could explain some or all of the association. The 65% attributable risk estimate is striking, but it depends on the assumption that the association is causal, an assumption the data alone cannot confirm.

The study also cannot determine whether specific aspects of type 1 diabetes management - glycemic variability, frequency of hypoglycemic episodes, type of insulin regimen - modify the dementia risk. Those are the questions that would inform clinical practice most directly, and they will require studies with different designs and richer clinical data.

What clinicians and patients should take from this

The practical implications are cautious but real. Clinicians caring for older adults with type 1 diabetes should be aware that cognitive decline may be more common in this population than previously recognized. Screening for early cognitive changes during routine visits, optimizing glycemic control to reduce both sustained hyperglycemia and dangerous hypoglycemic episodes, and aggressively addressing cardiovascular risk factors are all reasonable steps, even in the absence of definitive evidence that they prevent dementia specifically in this group.

For patients and families, the findings add cognitive health to the already long list of long-term concerns associated with type 1 diabetes - alongside cardiovascular disease, kidney disease, retinopathy, and neuropathy. That is not welcome news. But it is the kind of honest information that enables people to plan ahead, advocate for appropriate screening, and push for the research that is still needed to understand - and eventually disrupt - the connection between lifelong diabetes and late-life cognitive decline.

The study was supported by the National Institutes of Health.